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ABSTRACT 
 
The purpose of the present study was to determine the antidotal effect of Datura 
stramonium aqueous seed extract (DSE) in treatment of toxicity of malathion. Twenty-five 
albino rats were evenly divided into five groups including the control. The control group (5) 
and the other four groups (1, 2, 3 and 4) received initially 500 mg/kg body weight of 
malathion. After ½ an hour, groups 2, 3, and 4 received 5, 7.5 mg/kg of DSE and 17 mg/kg 
atropine sulphate, respectively; this treatment was repeated after 4 hours, and group 5 was 
left as unintoxicated, untreated (control). Blood samples were collected three times, after ½ 
an hour of the first treatment, after ½ an hour of the second treatment and after 24 hours. In 
the treated groups, the level of the enzyme cholinesterase significantly increased towards the 
normal level, while the levels of ALT, AST and ALP significantly decreased. The rats were 
sacrificed after 24 hours, and tissue specimens were processed for histopathology. The 
result of histopathology showed normal internal organs in the groups dosed with 7.5 mg/kg 
DSE and the group treated with the drug. The groups treated with 5 mg/kg DSE showed 
mild toxicity in the internal organs and slightly high levels of serum enzymes. The 
malathion group (untreated) showed typical signs of toxicity in the internal organs and high 
level of serum enzymes. The study concluded that the dose of 7.5 mg/kg DSE possesses 
antidotal effect against malathion toxicity and has the same effect of atropine sulphate in 
treatment of toxicity and indicates that the protective action of DSE against the insecticide 
tested was dose dependant. This effect is most probably due to the presence of the atropine-
like alkaloids in D. stramonium that may possess central anticholinergic effects which 
minimize the action of acetylcholine at muscarinic receptor. 
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INTRODUCTION  
Plants have always played a major role in the treatment of animals' traumas and 
diseases worldwide. They have been used as sources of modern drugs, either by providing 
pure compounds, starting materials for partial synthesis of useful compounds or models for 
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synthesis of new drugs. Datura stramonium which belongs to the family Solanaceae is 
distributed throughout the warmer portion of the whole world.  In Sudan, D. stramonium is 
widely distributed in Kassala, Dongla, Barber, Nuba mountains and Khartoum Province 
(Ali, 1995). All parts of Jimson weed are poisonous. Leaves and seeds are the usual causes 
of poisoning, but are rarely eaten due to their strong odour and unpleasant taste (Cornell 
University, 2009). The toxic principles of the plant are tropane belladonna alkaloids which 
possess strong anticholinergic properties (Ruhwald, 2005). These alkaloids include, 
hyoscyamine (in stems, leaves, roots and seeds), hyoscine inroots and Atropine (d,l-
hyoscyamine) and scopolamine (l-hyosci ne) (Miraldi et al., 2001;. Steenkamp et al., 2004).  
The plant has a long history of use as a herbal medicine and its medicinal properties are 
notable. The leaves, flowering tops and seeds are anodyne, antiasthmatic, antispasmodic, 
hallucinogenic, hypnotic, mydriatic and narcotic (Chiej, 1984; Launert, 1981; Bown, 1995). 
It is, also, used as analgesic, anthelmintic and anti-inflammatory in the treatment of stomach 
and intestinal pain due to worm infestation, toothache and fever from inflammations 
(Tsarong, 1994). Jimson weed extract was used as a protective agent in severe 
Organophosphate toxicity by Theodore et al. (2004). They have proved that pretreatment 
with Jimson weed extract significantly increased survival following severe dichlorvos 
exposure in white rats. Malathion is one of the most commonly used Organophosphate; it 
has a wide range of control uses in agriculture and has been used to control, stored grain and 
forest pests (Brenner, 1992). The objective of this study was to investigate the use of D. 
stramonium seed extract in treatment of malathion toxicity in correlation with doses 
compared to a reference drug Atropine sulphate. 
 
MATERIALS AND METHODS 
The aqueous extract of D. stramonium seeds was used as post treatment to toxicity 
induced by an organophosphorus (malathion). Twenty five male and female white Albino 
rats of weighing 115-180 gm, were obtained from the Medicinal and Aromatic Plant 
Research Institute, National Centre for Research, Khartoum, Sudan.  The animals were 
weight- distributed and allotted randomly to 5 groups of 5 rats each. Group 1 received only 
malathion at a dose of 500 mg/kg body weight (BW). Group 2 was exposed to 500 mg/kg 
BW and after half an hour treated with D. stramonium seeds extract 5 mg/kg BW, 
intraperitonially (I.P). Group 3 received 500 mg/kg BW malathion and after half an hour 
was treated with D. stramonium seeds extract at a dose of 7.5 mg/kg BW I/P. Rats in group 
4 were exposed to toxicity by malathion 500 mg/kg BW orally and post treated with 17 
mg/kg BW Atropine sulphate I/P. The treatment dose of Atropine sulphate and D. 
stramonium aqueous extract was repeated after four hours. Group 5 served as unintoxicated 
and untreated control group. 
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Clinical signs were observed and blood samples were collected from the ocular vein 
three times. The first blood samples were collected after 30 minutes after administration of 
D. stramonium seed extract and Atropine sulphate. The second collection was after 30 
minutes after the second treatment with D. stramonium seed extract and atropine. The third 
collection was after twenty four hours from the second treatment (by D. stramonium seed 
extract and atropine). Sera were analyzed for the concentration of cholinesterase and for the 
activities of Alanine amino transferase (ALT), Aspartate amino transferase (AST) and 
Alkaline Phosphatase (ALP). The concentrations of metabolic indicators, total protein, 
albumin, globulin, urea and creatinine were also evaluated. The rats were scarified after 24 
hours and tissue specimens of livers, hearts, kidneys, spleens and brains were fixed in 10% 
buffered formalin and processed for histopathology. 
RESULTS 
Signs were noted by observing access of rats to food and water since there were no 
obvious clinical signs except for dullness and slow movement during on the first 30 
minutes. Two hrs and 30 minutes after the beginning of the experiment, the rats in groups 2, 
3 and 4 treated with the plant extract and atropine sulphate showed normal access to water, 
but remained inappitant. The untreated group (malathion group) showed no response to the 
presence of water. Three hours later (one hour after the second dose), only the treated 
groups started to take food. Table (1) shows pathological changes and serum constituents of 
rats post-treated by D. stramonium seed extract (two doses 5 mg/kg BW/rat and 7.5 mg/kg 
BW/rat) with regard to Atropine sulphate 
DISCUSSION 
The present study attempted to determine the efficacy of D. stramonium seed extract 
as an antidote to the toxicity of an insecticide organophosphate evaluation of D. stramonium 
seed extract as a post treatment in malathion poisoning had showed significant increase in 
ALT during the first 30 minutes which indicated tissue damage. A single intraperitoneal or 
oral doses of malathion, trichlorofon or dioxathion in rats, an increase in the activities of  
liver tyrosine transaminase and alkaline phosphatase, as well as a decrease in the level of 
adrenal ascorbic acid (Murphy, 1966). The results of this experiment support the hypothesis 
that acute poisoning may produce metabolic alterations which are mediated through the 
pituitary-adrenal system. Thirty minutes after the second dose, the levels of AST, ALT and 
ALP in groups 2, 3 and 4 (D. stramonium 5 mg/kg, D. stramonium 7.5 mg/kg and Atropine 
sulphate) were reduced and were significantly different from the control group. After 24 
hours, the levels of these enzymes in all the groups, were reduced almost to the normal level 
except for the malathion group. Group 2 (D. stramonium 5 mg) had slightly higher enzymes 
levels than groups 3 and 4 (D. stramonium 7.5 mg/kg and atropine). These results together 
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with histopathological changes were similar to pathological lesions of groups 3 and 4 (D. 
stramonium 7.5 mg/kg and atropine sulfate) indicating the effective action of the treatment. 
 The levels of total protein, globulin and albumin; were highly reduced in the 
malathion group and the levels of the metabolic indicators had lesser values compared to 
groups 3 and 4 (D. stramonium 7.5 mg/kg and atropine); another evidence of the extract 
protective action. There was an apparent reduction in cholinesterase activity in all the 
groups during the first 30 minutes after the first dose and this was recorded by Frawley et al. 
(1957), who studied simultaneous administration of malathion and ethyl pnitrophenyl 
thionobenzenephosphate (EPN) which potentiated cholinesterase inhibitory effect of 
malathion in mice, rats and dogs. The level of this enzyme began to increase after 24 hours 
especially in groups 3 and 4 (D. stramonium 7.5 mg/kg and atropine) which means that the 
body began to eliminate malathion from its tissues.  The usual duration of anticholinergic 
effect following exposure to the D. stramonium extract is 12–48 hours (Levy 1977, Chang 
et al., 1999; Clancy et al., 2001). This long duration of clinical effect has a potential 
advantage in the treatment of OP toxicity since the effect of most OP is long. Patients 
treated with this extract may not require additional doses of antidote. D. stramonium crosses 
the blood–brain barrier, and has central anticholinergic effects and antagonizes the 
peripheral muscarinic receptor. (Clancy et al., 2001) The high concentrations of these 
anticholinergic alkaloids in the D. stramonium seeds render the extract of this plant a 
potentially useful agent for the treatment of organophosphorus toxicity.  It is concluded that 
the protective action of D. stramonium seed extract against insecticide is dose dependant 
and that treatment with D. stramonium seed extract has a significant protective action in a 
rat model of organophosphorus poisoning. 
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Table 1: Pathological changes in rats treated by D. stramonium  
changes  Pathological changes  
Groups  
Group 1  Pale liver with haemorrhages. The heart, spleen, brain, and kidneys were 
characterized by severe congestion and haemorrhages.  
Group 2 Distended stomach, severe congestion in the heart, spleen with fatty changes in 
the liver and scattered spots of necrosis in it's upper surface.  
Group 3 Distended stomach, fatty changes and congestion in the liver and kidney, no 
significant changes in the heart and brain  
Group 4 Distended stomach with gases in three rats. The liver is slightly congested. The 
kidney showed fatty changes. No significant changes, in the heart and brain 
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Table 2. Histological changes in serum constituents of rats post-treated by D. stramonium 
seed extract (two doses 5mg/kg b.wt/ rat and  7.5 mg/kg b.wt/ rat) with regard to a 
reference drug –Atropine sulphate 
 changes  Histological changes: 
Groups 
Group1  Liver: congestion, generalized necrosis land lymphocytic infiltration.  
Heart-and kidney: congestion with lymphocytic infiltration, and severe necrosis 
of the cortical and meddullary tubules plus necrosis of the glomeruli..  
spleen :severe congestion  
Brain :severe leucocytic infiltration  
Group 2  Liver :congestion in the central vein, fatty change and centrilobular necrosis.- 
Heart, kidney and spleen: was severely congested with lymphocytic infiltration..  
Brain :mild infiltration 
Group3  Liver fatty change -slight necrosis of the hepatocytes.                                    
heart-slight congestion                                                                                         
The kidneys lymphocytic infiltration, shrinkage of glomeruli, with fatty of the 
central and meddullary tubules.                                                                        
Spleen-: slight haemosidrosis .                                                                            
brain no significant histopathological change 
Group4  Liver: slight congestion, fatty change and slight necrosis. – 
Heart-:no histological changes.  
Kidneys: lymphocytic infiltration, shrinkage of glomeruli, with fatty changes of 
the meddullary tubules 
. The spleens: showed slight haemosidrosis.  
The brain : no significant histopathological change.  
 
  
445 
Changes in the serum constituents: 
Table (3) and Fig. (1). Changes in serum constituents of rats post-treated by D. stramonium seed 
extract (two doses 5 mg/kg b.wt/ rat and  7.5 mg/kg b.wt/ rat) with regard to a reference drug 
–Atropine sulphate 
Groups Changes 
After 30 minutes of administration of the 
first dose of D. stramonium seed extract 
and atropine 
After 30 minutes from 
the second treatment  
 
After 24 hours  
 
 Group1  cholinesterase, was significantly reduced  
AST ,ALP and urea, increased significantly 
-ALT increased significantly -No 
significant changes in total protien, creatinie 
and albumin  
ALT, AST and ALP and 
urea increased significantly 
cholinesterase .Total 
protein and albumin was 
significantly reduced  
ALT, AST, ALP urea 
and creatinine 
increased, 
cholinesterase , Total 
protein and albumin are 
insignificantly reduced 
,  
 Group 2  cholinesterase, was significantly reduced 
AST ,ALP and urea, increased significantly 
-No significant changes in total protien, 
creatinie and albumin  
reduction in the level of 
cholinesterase ,Total 
protein and albumin -ALT, 
AST and ALP and urea  
are reduced  
normal levels of ALT 
and ALP, while the 
level of AST was 
significantly -increased 
. cholinesterase , Total 
protein and albumin are 
insignificantly reduced 
,  
 Group 3  cholinesterase, was significantly reduced -
AST ,ALP and urea, increased significantly 
-No significant changes in total protien, 
creatinie and albumin  
cholinesterase was 
significantly increased -
ALT, AST and ALP and 
urea  are reduced  
,total protein and albumin  
normal levels of 
cholinesterase ,ALT, 
AST and ALP , level of 
total protein and 
albumin were not 
significantly reduced  
Group 4  cholinesterase, was significantly reduced -
AST and urea, increased significantly -No 
significant changes in total protien , 
creatinie and albumin  
cholinesterase was 
significantly increased -
ALT, AST and ALP and 
urea  are reduced  
,total protein and albumin  
normal levels of 
cholinesterase ,ALT, 
AST and ALP , level of 
total protein and 
albumin were not 
significantly reduced  
.  
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Table 4.  Analysis of variance and Average (mean ±SE) values of serum constituents of rats post-treated with D. stramonium seed aqueous extracts and 
intoxicated with malathion:  (TIME) After 30 minutes from the first treatment dose 
groups ALT(i.u/l) AST(i.u/l) ALP(i.u/l) T,Protien(g/dl) Globulin(g/dl) Albumin(g/dl) Urea (mg/dl) Creatinine(mg/dl) Cholinesterase(nkal)t 
F value 3.43* 1.57* 2.99* 1.08 1.07 3.25 3.61* 3.27 9.26* 
G1 51.0±  20.5 a 286.2±2.5.a 200.4±17.7 b 7.2 ±0.3a 3.2±0.4a 3.5 ±0.1ab 54.0±3.1a 0.620.1a 159.33 38.7 cd 
G 2 45.80±28.4ab 220.8±ab4.0b 197.2±27.3 b 7.3±0.3 a 3.7 ±a 3.3 ±0.1b 47.8 ±3.3bc 0.62a 126.67 d 
G 3 51.0011.6±a 227.0±ab4.7b 182.0±26.6 b 7.9±0.2 a 3.5±0.1a 3.2±0.2 b 42.8±3.0 bc 0.72±0.02 a 361.048.7 ab 
G4 52.00±19.1a 242±ab2.8b 118.6±8.9a 6.80±0.5a 2.7 ±0.5a 3.6±0.2ab 50.6±3.7 bc 0.880.1 a 363.6737.2 ab 
G5 33.33 bc 178.33ab 110.0a 7.6 a 4.1± a 4.13a 38.67c 0.83 a 477.5 a 
 )EMIT( After 30 minutes from the second treatment dose 
groups ALT(i.u/l) AST(i.u/l) ALP(i.u/l) T,Protien(g/dl) Globulin(g/dl) Albumin(g/dl) Urea(mg/dl) Creatinine Cholinesterase(nkal)t 
F value 5.87 5.72 5.07 3.23 4.31 3.19 1.187 1.95 16.08 
G1 82.4 ±15.2a 293.80 ±15.1a 196.2±5.3a 5.8±0.2 b 2.4±0.3b 3.16±0.3 b 48.80 ± 5.7a 0.8±0.1 ab 277.00 ±28.7c 
G2 42.6±31.2 b 230.0 ±5.2 b 137.60 ±18.1b 6.9 ± 0.1ab 3.6±0.3a 3.2 ±0.1ab 47.80±3.3a 0.6±0.1 b 291.67±30.4 c 
G3 47.8±10.2b 219.00±3.4  b 115.80±20.5b 6.84±0.3 ab 3.2±0.2a 3.52±0.3ab 40. 0± 8.9a 0.9± 0.9a 351.67±40. 2 ab 
G4 50.2±b9.5b 190.8 ±4.3b 117.00±10.5 b 7.00±0.6a 3.78 ±0.1a 3.1 ±b 50.25 ±a 0.72±0.3 ab 394.67 ±22.1ab 
G5 29.75±4.7b 173.75 ±1.7 b 111.25±7.7 b 7.62±0.2 a 3.6±0.3a 4.05±0.1 a 38.25 ±0.6a 0.75±0 ab 486.00±103.5a 
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(TIME) after 24 hours  
groups ALT(i.u/l) AST(i.u/l) ALP(i.u/l) T,Protien(g/dl) Globulin(g/dl) Albumin(g/dl) Urea (mg/dl) Creatinine Cholinesterase(nkal)t 
F value 4.69 8.14 17.23 5.46 4.89 6.63 1.58 3.72 8.20 
G1 91.40 ±28a 317.60 ±68a 210.60 ±10.9a 4.8 ±0.7c 1.6 ±0.6b 2.72±0 b 62.60±5.8b 0.94±0.2 a 216.67±10.3 b 
G2 45.60±23.7 b 257.4±5.5 b 110.20 ±15.2b 5.80 ±0.4bc 2.8±0 a 2384±0.2b 48.20±5.6 a 0.5±0.6 c 253.00±36.5 b 
G3 38.00 ±2.07 b 218.4±5.6bc 105.60 ±13.2b 7.24 ±0.6ab 3.5±0.2 a 3.68±0.4a 40.20±6.3a 0.8 ±0.1ab 385.00 ±72.6a 
G4 35.00± 8.3b 188.80± 1.2c 106.60±5.2 b 6.18 ±0.2abc 2.84±0.4 a 3.34 ±0.1ab 40.40± 3.8 a 0.58±0.1 bc 394.33±57a 
G5 29.75±3.8b 173.75±1.7 c 105.60 ±7.2b 7.650 ±0.2a 3.85±0.1a 3.97±0a 37.75±0.6 a 0.8±0.1ab 485.67±45 a 
Means with the same letter are not significantly different (.P> 0.05) *At (4, 20) degrees of freedom. ** 5 
G1=only Malathion 500mg/kg/body weight. 
G2=Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body weight 
G3= Malathion 500mg/kg /body weight and Datura seed extract 7.5mg /kg/body weight. 
G4 =.malthion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body weight. 
G5=Control 
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Fig. (1). Comparison between ALT levels in rats treated with malathion, D. stramonium seed 
extract and malathion and Atropine and malathion 
  
G1= Only Malathion 500mg/kg/body weight  
G3= Malathion 500mg/kg /body weight and Datura seeds extracts at a dose of 7.5mg/kg /body weight 
G2= Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body weight 
G4= Malathion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body weight 
G5= Control   
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Fig. (2). Comparison between AST levels in rats treated with malathion, D. stramonium seed extract 
and malathion and Atropine sulphate and malathion  
G1= Only Malathion 500mg/kg/body weight  
 G2= Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body weight  
  G3= Malathion 500mg/kg /body weight and Datura seeds extracts at a dose of 7.5mg/kg/body weight   
G4= Malathion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body weight 
G5= Control 
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Fig. (3) Comparison between ALP levels in rats treated with malathion, D.  stramonium seed extract and 
malathion and Atropine sulphate  and malathion  
 
G1=only Malathion 500mg/kg/body weight.    
G3= Malathion 500mg/kg /body weight and Datura seeds extracts at a dose of  7.5mg/kg /body weight 
G2= Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body   weight 
G4= Malathion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body weight 
G5=Co 
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Fig (4) Comparison between cholinesterase levels in rats treated with malathion, D. stramonium 
seed extract and malathion and Atropine sulphate and malathion  
G1= Only malathion 500mg/kg/body weight  
G2= Malathion 500mg/kg /body weight and Datura seed extract 5mg /kg/body weight 
G3= Malathion 500mg/kg /body weight and Datura seeds extracts at a dose of 7.5mg/kg /body weight 
G4= Malathion 500mg /kg/body weight and Atropine Sulphate 17 mg/kg/body weight 
G5= Control   
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